TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Thern Medicine AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 1,774 | 1,285 | 249 |
Financial expenses | 33 | 23 | 0 |
Earnings before taxes | 136 | 210 | -87 |
EBITDA | 104 | 244 | -86 |
Total assets | 525 | 433 | 111 |
Current assets | 402 | 298 | 70 |
Current liabilities | 518 | 356 | 126 |
Equity capital | 7 | 77 | -134 |
- share capital | 50 | 50 | 50 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 1.3% | 17.8% | -120.7% |
Turnover per employee | 887 | 642 | 124 |
Profit as a percentage of turnover | 7.7% | 16.3% | -34.9% |
Return on assets (ROA) | 32.2% | 53.8% | -78.4% |
Current ratio | 77.6% | 83.7% | 55.6% |
Return on equity (ROE) | 1942.9% | 272.7% | 64.9% |
Change turnover | 489 | 1,036 | -212 |
Change turnover % | 38% | 416% | -46% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.